Received Mar 23, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TYP | TYPHOID LIVE ORAL TY21A (VIVOTIF) | BERNA BIOTECH, LTD. | 3 | 3004008 | — |
The patient lost the fourth dose of Vivotif vaccine and was able to take only first three doses; Case reference number US-BN-2024-002271 is a spontaneous case report initially received from a nurse via agency (reference number USBAV24-1817) on 30-Jul-2024 and concerns a 19-year-old male patient. The patient's medical history and concomitant medication details were not provided. On 15-Jul-2024, the patient took the first dose of Vivotif vaccine (batch number: 3004008, *expiry date: 31-Oct-2024*), at a dose of a pill, orally, for indication reported as prior to travel. On 17-Jul-2024, two days after the first dose of Vivotif, the patient took the second dose of Vivotif vaccine (batch number: 3004008, *expiry date: 31-Oct-2024*), at a dose of a pill, orally. On 19-Jul-2024, four days after the first dose of Vivotif, the patient took the third dose of Vivotif vaccine (batch number: 3004008, *expiry date: 31-Oct-2024*), at a dose of a pill, orally. On unspecified date, an unknown amount of time after the first dose of Vivotif, as reported the *patient lost the fourth dose of Vivotif* and was only able to take three pills (explicitly coded as 'incomplete course of vaccination'). At the time of *follow up report*, it was unknown if the patient experienced any adverse events due to Vivotif vaccine. All follow-up information is blended into the case narrative above, with the latest information presented between asterisks (*). Follow up information received from a nurse on 23-Aug-2024: New information included patient initials, Vivotif dosage information and event verbatim was updated. Non-significant follow up was downloaded from VAERS on 09-May-2025 included new reference number Administrative update performed within the case: Worldwide Unique Case Identification Number (WWID) updated from US-20240730-688d25 to US-BAVARIAN NORDIC A/S-US-BN-2024-002271, in accordance with ICH guidance on WWID formatting.; Reporter's Comments: A 19-year-old male patient lost the fourth dose of Vivotif and was only able to take three pills which is considered as incomplete course of vaccination. Incomplete course of vaccination is considered listed per company convention. At this point, it was unknown if the patient experienced any adverse events due to Vivotif vaccine. The patient's medical history and concomitant medication details were not provided. Causality is assessed as not related to suspect product but to human factor. The case is non-serious.; Sender's Comments: A 19-year-old male patient lost the fourth dose of Vivotif and was only able to take three pills which is considered as incomplete course of vaccination. Incomplete course of vaccination is considered listed per company convention. At this point, it was unknown if the patient experienced any adverse events due to Vivotif vaccine. The patient's medical history and concomitant medication details were not provided. Causality is assessed as not related to suspect product but to human factor. The case is non-serious.
Comments: NONE